// App-Quantinova.ai

83 : Minimal Disease Activity among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component

Researchers

Presenter

  • Proton Rahman

Principal Investigators

  • Louis Bessette

  • Francois Nantel

  • Brendan Osborne

  • Cathy Tkaczyk

  • Philip Baer

  • Suneil Kapur

  • Antonio Avina-Zubieta

  • Regan Arendse

  • Emmanouil Rampakakis

  • Eliofotisti Psaradellis

  • Karina Maslova

  • Allen Lehman

Medical Centers

  • Memorial University, St. John's, NF, Canada

  • Institut de Rhumatologie, Montreal, QC, Canada

  • Univ of Ottawa, Ottawa, Canada

  • Arthritis Research Centre of Canada, Richmond, BC, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved